Paradoxical aspects of parkinsonian tremor
Identifieur interne : 000727 ( Main/Corpus ); précédent : 000726; suivant : 000728Paradoxical aspects of parkinsonian tremor
Auteurs : Paul S. FishmanSource :
- Movement Disorders [ 0885-3185 ] ; 2008-01-30.
English descriptors
- KwdEn :
Abstract
Although resting tremor is the most identifiable sign of Parkinson's disease, its underlying basis appears to be the most complex of the cardinal signs. The variable relationship of resting tremor to other symptoms of PD has implications for diagnosis, prognosis, medical and surgical treatment. Structural lesions very rarely cause classic resting tremor, with likely contributions to tremor by a network of neurons both within and outside the basal ganglia. Patients with only resting tremor show dopaminergic deficits with radioligand imaging, but severity of tremor correlates poorly in such dopamine imaging studies. Correlation of tremor severity to changes in radioligand studies is also limited by the use of mostly qualitative measures of tremor severity. A complex pharmacologic basis of parkinsonian resting tremor is supported by treatment studies. Although levodopa is clearly effective for resting tremor, several agents have shown efficacy that appears to be superior or additive to that of levodopa including anticholinergics, clozapine, pramipexole, and budipine. Although the thalamus has the greatest body of evidence supporting its role as an effective target for surgical treatment of tremor, recent studies suggest that the subthalamic nucleus may be a reasonable alternative target for patients with Parkinson's disease and severe tremor as the predominant symptom. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21736
Links to Exploration step
ISTEX:0B7C9E41614142A2F0AE422A5B9B00FB5387329FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Paradoxical aspects of parkinsonian tremor</title><author><name sortKey="Fishman, Paul S" sort="Fishman, Paul S" uniqKey="Fishman P" first="Paul S." last="Fishman">Paul S. Fishman</name><affiliation><mods:affiliation>Department of Neurology, University of Maryland, School of Medicine and The Baltimore VAMC, Baltimore, Maryland 21201</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0B7C9E41614142A2F0AE422A5B9B00FB5387329F</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.21736</idno><idno type="url">https://api.istex.fr/document/0B7C9E41614142A2F0AE422A5B9B00FB5387329F/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000727</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Paradoxical aspects of parkinsonian tremor</title><author><name sortKey="Fishman, Paul S" sort="Fishman, Paul S" uniqKey="Fishman P" first="Paul S." last="Fishman">Paul S. Fishman</name><affiliation><mods:affiliation>Department of Neurology, University of Maryland, School of Medicine and The Baltimore VAMC, Baltimore, Maryland 21201</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-01-30">2008-01-30</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="168">168</biblScope><biblScope unit="page" to="173">173</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">0B7C9E41614142A2F0AE422A5B9B00FB5387329F</idno><idno type="DOI">10.1002/mds.21736</idno><idno type="ArticleID">MDS21736</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>DBS</term><term>Parkinson's disease</term><term>tremor</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although resting tremor is the most identifiable sign of Parkinson's disease, its underlying basis appears to be the most complex of the cardinal signs. The variable relationship of resting tremor to other symptoms of PD has implications for diagnosis, prognosis, medical and surgical treatment. Structural lesions very rarely cause classic resting tremor, with likely contributions to tremor by a network of neurons both within and outside the basal ganglia. Patients with only resting tremor show dopaminergic deficits with radioligand imaging, but severity of tremor correlates poorly in such dopamine imaging studies. Correlation of tremor severity to changes in radioligand studies is also limited by the use of mostly qualitative measures of tremor severity. A complex pharmacologic basis of parkinsonian resting tremor is supported by treatment studies. Although levodopa is clearly effective for resting tremor, several agents have shown efficacy that appears to be superior or additive to that of levodopa including anticholinergics, clozapine, pramipexole, and budipine. Although the thalamus has the greatest body of evidence supporting its role as an effective target for surgical treatment of tremor, recent studies suggest that the subthalamic nucleus may be a reasonable alternative target for patients with Parkinson's disease and severe tremor as the predominant symptom. © 2007 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Paul S. Fishman MD, PhD</name><affiliations><json:string>Department of Neurology, University of Maryland, School of Medicine and The Baltimore VAMC, Baltimore, Maryland 21201</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>tremor</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>DBS</value></json:item></subject><articleId><json:string>MDS21736</json:string></articleId><language><json:string>eng</json:string></language><abstract>Although resting tremor is the most identifiable sign of Parkinson's disease, its underlying basis appears to be the most complex of the cardinal signs. The variable relationship of resting tremor to other symptoms of PD has implications for diagnosis, prognosis, medical and surgical treatment. Structural lesions very rarely cause classic resting tremor, with likely contributions to tremor by a network of neurons both within and outside the basal ganglia. Patients with only resting tremor show dopaminergic deficits with radioligand imaging, but severity of tremor correlates poorly in such dopamine imaging studies. Correlation of tremor severity to changes in radioligand studies is also limited by the use of mostly qualitative measures of tremor severity. A complex pharmacologic basis of parkinsonian resting tremor is supported by treatment studies. Although levodopa is clearly effective for resting tremor, several agents have shown efficacy that appears to be superior or additive to that of levodopa including anticholinergics, clozapine, pramipexole, and budipine. Although the thalamus has the greatest body of evidence supporting its role as an effective target for surgical treatment of tremor, recent studies suggest that the subthalamic nucleus may be a reasonable alternative target for patients with Parkinson's disease and severe tremor as the predominant symptom. © 2007 Movement Disorder Society</abstract><qualityIndicators><score>6.664</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>3</keywordCount><abstractCharCount>1421</abstractCharCount><pdfWordCount>4180</pdfWordCount><pdfCharCount>27462</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>207</abstractWordCount></qualityIndicators><title>Paradoxical aspects of parkinsonian tremor</title><genre><json:string>review-article</json:string></genre><host><volume>23</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>6</total><last>173</last><first>168</first></pages><issn><json:string>0885-3185</json:string></issn><issue>2</issue><subject><json:item><value>Review</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1002/mds.21736</json:string></doi><id>0B7C9E41614142A2F0AE422A5B9B00FB5387329F</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/0B7C9E41614142A2F0AE422A5B9B00FB5387329F/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/0B7C9E41614142A2F0AE422A5B9B00FB5387329F/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/0B7C9E41614142A2F0AE422A5B9B00FB5387329F/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Paradoxical aspects of parkinsonian tremor</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2008</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Paradoxical aspects of parkinsonian tremor</title><author><persName><forename type="first">Paul S.</forename><surname>Fishman</surname></persName><roleName type="degree">MD, PhD</roleName><note type="correspondence"><p>Correspondence: Department of Neurology, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, Maryland 21201</p></note><affiliation>Department of Neurology, University of Maryland, School of Medicine and The Baltimore VAMC, Baltimore, Maryland 21201</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-01-30"></date><biblScope unit="volume">23</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="168">168</biblScope><biblScope unit="page" to="173">173</biblScope></imprint></monogr><idno type="istex">0B7C9E41614142A2F0AE422A5B9B00FB5387329F</idno><idno type="DOI">10.1002/mds.21736</idno><idno type="ArticleID">MDS21736</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2008</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Although resting tremor is the most identifiable sign of Parkinson's disease, its underlying basis appears to be the most complex of the cardinal signs. The variable relationship of resting tremor to other symptoms of PD has implications for diagnosis, prognosis, medical and surgical treatment. Structural lesions very rarely cause classic resting tremor, with likely contributions to tremor by a network of neurons both within and outside the basal ganglia. Patients with only resting tremor show dopaminergic deficits with radioligand imaging, but severity of tremor correlates poorly in such dopamine imaging studies. Correlation of tremor severity to changes in radioligand studies is also limited by the use of mostly qualitative measures of tremor severity. A complex pharmacologic basis of parkinsonian resting tremor is supported by treatment studies. Although levodopa is clearly effective for resting tremor, several agents have shown efficacy that appears to be superior or additive to that of levodopa including anticholinergics, clozapine, pramipexole, and budipine. Although the thalamus has the greatest body of evidence supporting its role as an effective target for surgical treatment of tremor, recent studies suggest that the subthalamic nucleus may be a reasonable alternative target for patients with Parkinson's disease and severe tremor as the predominant symptom. © 2007 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>tremor</term></item><item><term>DBS</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2005-09-15">Received</change><change when="2007-08-15">Registration</change><change when="2008-01-30">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/0B7C9E41614142A2F0AE422A5B9B00FB5387329F/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body" wicri:toSee="Element #text; element #text"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"> <header> <publicationMeta level="product"> <publisherInfo> <publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName> <publisherLoc>Hoboken</publisherLoc> </publisherInfo> <doi registered="yes">10.1002/(ISSN)1531-8257</doi> <issn type="print">0885-3185</issn> <issn type="electronic">1531-8257</issn> <idGroup> <id type="product" value="MDS"></id> </idGroup> <titleGroup> <title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title> <title type="short">Mov. Disord.</title> </titleGroup> </publicationMeta> <publicationMeta level="part" position="20"> <doi origin="wiley" registered="yes">10.1002/mds.v23:2</doi> <numberingGroup> <numbering type="journalVolume" number="23">23</numbering> <numbering type="journalIssue">2</numbering> </numberingGroup> <coverDate startDate="2008-01-30">30 January 2008</coverDate> </publicationMeta> <publicationMeta level="unit" type="reviewArticle" position="20" status="forIssue"> <doi origin="wiley" registered="yes">10.1002/mds.21736</doi> <idGroup> <id type="unit" value="MDS21736"></id> </idGroup> <countGroup> <count type="pageTotal" number="6"></count> </countGroup> <titleGroup> <title type="articleCategory">Review</title> <title type="tocHeading1">Reviews</title> </titleGroup> <copyright ownership="thirdParty">Copyright © 2007 Movement Disorder Society</copyright> <eventGroup><event type="manuscriptReceived" date="2005-09-15"></event><event type="manuscriptRevised" date="2007-05-30"></event><event type="manuscriptAccepted" date="2007-08-15"></event><event type="firstOnline" date="2007-10-31"></event><event type="publishedOnlineFinalForm" date="2008-01-25"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2007-10-31"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup> <numberingGroup> <numbering type="pageFirst">168</numbering> <numbering type="pageLast">173</numbering> </numberingGroup> <correspondenceTo>Department of Neurology, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, Maryland 21201</correspondenceTo> <linkGroup> <link type="toTypesetVersion" href="file:MDS.MDS21736.pdf"></link> </linkGroup> </publicationMeta> <contentMeta> <countGroup> <count type="figureTotal" number="0"></count> <count type="tableTotal" number="0"></count> <count type="referenceTotal" number="79"></count> <count type="wordTotal" number="4715"></count> </countGroup> <titleGroup> <title type="main" xml:lang="en">Paradoxical aspects of parkinsonian tremor</title> <title type="short" xml:lang="en">Paradoxical Aspects of Parkinsonian Tremor</title> </titleGroup> <creators> <creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"> <personName> <givenNames>Paul S.</givenNames> <familyName>Fishman</familyName> <degrees>MD, PhD</degrees> </personName> <contactDetails> <email>pfishman@umaryland.edu</email> </contactDetails> </creator> </creators> <affiliationGroup> <affiliation xml:id="af1" countryCode="US" type="organization"> <unparsedAffiliation>Department of Neurology, University of Maryland, School of Medicine and The Baltimore VAMC, Baltimore, Maryland 21201</unparsedAffiliation> </affiliation> </affiliationGroup> <keywordGroup xml:lang="en" type="author"> <keyword xml:id="kwd1">Parkinson's disease</keyword> <keyword xml:id="kwd2">tremor</keyword> <keyword xml:id="kwd3">DBS</keyword> </keywordGroup> <abstractGroup> <abstract type="main" xml:lang="en"> <title type="main">Abstract</title> <p>Although resting tremor is the most identifiable sign of Parkinson's disease, its underlying basis appears to be the most complex of the cardinal signs. The variable relationship of resting tremor to other symptoms of PD has implications for diagnosis, prognosis, medical and surgical treatment. Structural lesions very rarely cause classic resting tremor, with likely contributions to tremor by a network of neurons both within and outside the basal ganglia. Patients with only resting tremor show dopaminergic deficits with radioligand imaging, but severity of tremor correlates poorly in such dopamine imaging studies. Correlation of tremor severity to changes in radioligand studies is also limited by the use of mostly qualitative measures of tremor severity. A complex pharmacologic basis of parkinsonian resting tremor is supported by treatment studies. Although levodopa is clearly effective for resting tremor, several agents have shown efficacy that appears to be superior or additive to that of levodopa including anticholinergics, clozapine, pramipexole, and budipine. Although the thalamus has the greatest body of evidence supporting its role as an effective target for surgical treatment of tremor, recent studies suggest that the subthalamic nucleus may be a reasonable alternative target for patients with Parkinson's disease and severe tremor as the predominant symptom. © 2007 Movement Disorder Society</p> </abstract> </abstractGroup> </contentMeta> </header> </component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Paradoxical aspects of parkinsonian tremor</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Paradoxical Aspects of Parkinsonian Tremor</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Paradoxical aspects of parkinsonian tremor</title></titleInfo><name type="personal"><namePart type="given">Paul S.</namePart><namePart type="family">Fishman</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, University of Maryland, School of Medicine and The Baltimore VAMC, Baltimore, Maryland 21201</affiliation><description>Correspondence: Department of Neurology, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, Maryland 21201</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2008-01-30</dateIssued><dateCaptured encoding="w3cdtf">2005-09-15</dateCaptured><dateValid encoding="w3cdtf">2007-08-15</dateValid><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">79</extent><extent unit="words">4715</extent></physicalDescription><abstract lang="en">Although resting tremor is the most identifiable sign of Parkinson's disease, its underlying basis appears to be the most complex of the cardinal signs. The variable relationship of resting tremor to other symptoms of PD has implications for diagnosis, prognosis, medical and surgical treatment. Structural lesions very rarely cause classic resting tremor, with likely contributions to tremor by a network of neurons both within and outside the basal ganglia. Patients with only resting tremor show dopaminergic deficits with radioligand imaging, but severity of tremor correlates poorly in such dopamine imaging studies. Correlation of tremor severity to changes in radioligand studies is also limited by the use of mostly qualitative measures of tremor severity. A complex pharmacologic basis of parkinsonian resting tremor is supported by treatment studies. Although levodopa is clearly effective for resting tremor, several agents have shown efficacy that appears to be superior or additive to that of levodopa including anticholinergics, clozapine, pramipexole, and budipine. Although the thalamus has the greatest body of evidence supporting its role as an effective target for surgical treatment of tremor, recent studies suggest that the subthalamic nucleus may be a reasonable alternative target for patients with Parkinson's disease and severe tremor as the predominant symptom. © 2007 Movement Disorder Society</abstract><subject lang="en"><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>tremor</topic><topic>DBS</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>168</start><end>173</end><total>6</total></extent></part></relatedItem><identifier type="istex">0B7C9E41614142A2F0AE422A5B9B00FB5387329F</identifier><identifier type="DOI">10.1002/mds.21736</identifier><identifier type="ArticleID">MDS21736</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2007 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000727 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000727 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:0B7C9E41614142A2F0AE422A5B9B00FB5387329F
|texte= Paradoxical aspects of parkinsonian tremor
}}
| This area was generated with Dilib version V0.6.23. |  |